Posted inAlzheimer's Disease Biogen Inc Brain Clinical Trials donanemab Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory United States your-feed-healthcare your-feed-science
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.